Malaz Boustani, M.D., MPH, detailed his career journey and his work in the areas of brain care research and implementation science on the podcast Outcomes Rocket. Dr. Boustani is a research scientist at Regenstrief Institute in Indianapolis, the founding director of the Center for Health Innovation and Implementation Science and associate director of the Indiana University Center for Aging Research at Regenstrief Institute.

Dr. Boustani shared with the podcast’s host how his desire to protect his brain and the brains of his family led him into healthcare research. He explained that he expanded his career focus include implementation science because he wanted everyone to benefit from research discoveries.

During the interview, Dr. Boustani also spoke about the Indiana University School of Medicine’s graduate certificate designed to create change agents in healthcare settings around the country.

Outcomes Rocket features successful healthcare leaders and influencers. Its goal is to inspire collaborative thinking to solve problems and create solutions to make healthcare better.

Listen to the entire interview below:

Dr. Boustani is the Richard M. Fairbanks Professor in Aging Research, IU School of Medicine.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 274-9062
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Jan 17, 2020 • News
Putting the “Why” in “EHR”: Expert on clinical information systems presents Regenstrief SAM Talk
Regenstrief Institute welcomed informatics expert James Cimino, M.D., for its January SAM (Scientists Advancing Medicine) Talk, presented in collaboration with the Indiana University School of Informatics and Computing at IUPUI Colloquia Series. Dr. Cimino has been a clinician, an informaticist, a systems architect and an educator for more than 30 years. His specialty is clinical…
Continue Reading >
Jan 15, 2020 • News
First randomized clinical trial found no harms from dementia screening in primary care
Dementia screening did not induce depression or anxiety in older adults Research scientists at Regenstrief Institute and Indiana University School of Medicine have conducted the first randomized controlled trial to evaluate the pros and cons of population screening for dementia. The researchers found no harm, as measured by patient reported depressive and anxiety symptoms, from…
Continue Reading >